Back to catalog NATTY+

Retatrutide

GLP-1/GIP/glucagon agonist

Research use only. Sold for in vitro laboratory research use only. Not a drug, supplement or cosmetic. Not for human consumption or any in vivo use.

Triple incretin receptor agonist — GLP-1, GIP and glucagon receptors — developed as Eli Lilly LY3437943. Currently in Phase 3 clinical evaluation (TRIUMPH programme, NCT05929066). Supplied lyophilized for in vitro research use only; not an approved drug product.

Sizes & pricing

SizePriceAvailabilityAdd to cart
20mg$150Sold outSold out
30mg$200In stock
50mg$300In stock
Purity>99%, HPLC & MS
TestingThird-party, COA per batch
FormLyophilized powder
Ships$10 · free over $100

What you receive

Handling & storage

Handling information describes the material as laboratory stock. It is not guidance for use in humans or animals.

0 in cart Checkout →